Cairo - Mubasher: The consolidated financial results of Minapharm Pharmaceuticals showed a 19.45% hike in net profits to EGP 148.41 million during 2019, compared to EGP 124.24 million a year earlier.
The company's sales rose to EGP 2.051 million last year from EGP 1.919 million in 2018, according to the company's disclosure to the Egyptian Exchange (EGX) on Monday.
In 2019, the company's standalone net profits declined by 36% year-on-year (YoY) to EGP 46.035 million from EGP 72.12 million in 2018.
